Thromb Haemost 2024; 124(11): 1084-1086
DOI: 10.1055/s-0044-1786030
Whole Blood Viscosity and Thromboembolic Events in Hospitalized Patients with COVID-19: Post hoc Analysis of the ATTACC/ACTIV-4a Trial
Daein Choi
1
Metabolism and Lipids Program, Cardiovascular Institute, Marie-Josee and Henry R Kravis Center for Cardiovascular Health, Icahn School of Medicine at Mount Sinai, The Mount Sinai Medical Center, New York, New York, United States
,
Joshua D. Froess
2
Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, United States
,
Patrick R. Lawler
3
Division of Cardiology, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada
,
Mathew D. Neal
4
Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, United States
,
Ryan Zarychanski
5
Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
,
Robert S. Rosenson
1
Metabolism and Lipids Program, Cardiovascular Institute, Marie-Josee and Henry R Kravis Center for Cardiovascular Health, Icahn School of Medicine at Mount Sinai, The Mount Sinai Medical Center, New York, New York, United States
,
on behalf of the ATTACC ACTIV-4a Investigators
› Author Affiliations
